Status:
COMPLETED
The PACE-MI Registry Study - Outcomes of Beta-blocker Therapy After Myocardial Infarction (OBTAIN)
Lead Sponsor:
Northwestern University
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
Myocardial Infarction
Eligibility:
All Genders
30+ years
Brief Summary
The purpose of the PACE-MI (OBTAIN) registry is: * Analyze beta-blocker dose response effect on outcome over two years * Explore gender and minority differences in beta-blocker utilization and outcom...
Detailed Description
Methods All patients admitted to the coronary care areas with an acute myocardial infarction will be entered into the registry. At the time of discharge from the coronary care unit, clinical data wil...
Eligibility Criteria
Inclusion
- Inclusion Criteria
- 1\. Consecutive patients admitted with a myocardial infarction documented by both of the following:
- cardiac enzymes (CPK elevation \> two times or troponin elevation \> three times the upper limit of normal for the lab)
- Electrocardiographic changes and/or symptoms consistent with myocardial infarction (i.e. chest pain, shortness of breath)
- No Exclusion Criteria
Exclusion
Key Trial Info
Start Date :
May 1 2009
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 1 2015
Estimated Enrollment :
7057 Patients enrolled
Trial Details
Trial ID
NCT00430612
Start Date
May 1 2009
End Date
October 1 2015
Last Update
April 24 2023
Active Locations (23)
Enter a location and click search to find clinical trials sorted by distance.
1
Little Rock Cardiology Clinic
Little Rock, Arkansas, United States, 72211
2
MemorialCare Heart and Vascular Institute - Long Beach Memorial Medical Center
Long Beach, California, United States, 90806
3
West Los Angeles VA Medical Center
Los Angeles, California, United States, 90073
4
Bridgeport Hospital
Bridgeport, Connecticut, United States, 06610